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Role of renal hemodynamics in the exaggerated natriuresis of essential
hypertension. Extracellular fluid volume expansion is known to produce
exaggerated natriuresis in essential hypertension. In order to assess the
role of hemodynamic and intrarenal physical factors upon natriuretic
response to central volume expansion, two hour water immersion (WI)
experiments were made in six uncomplicated essential hypertensives
and six normotensive healthy controls. Before and during WI we
measured mean arterial pressure (MAP), urine flow (V/mm), sodium
(UNaV) and potassium (UKV) excretion, glomerular filtration rate
(GFR), effective renal plasma flow (ERPF) and intrarenal (wedged)
venous pressure (IRVP). In comparison with normotensive controls,
the exaggerated natriuretic response in hypertensives (P < 0.05 for
UNaV during WI) was associated with an enhanced vasodilating re-
sponse as demonstrated by a greater increase in ERPF (P < 0.05) and
by a more pronounced fall in calculated renal precapillary resistances (P
<0.05). A more significant increase in IRVP was found in hypertensive
group (P < 0.05). Glomerular filtration rate (GFR) did not change in
either group during WI. MAP, unchanged in normotensives, was
significantly reduced in hypertensives (P < 0.05), while remaining in the
hypertensive range. These findings suggest that intrarenal physical
factors play a major role in determining the exaggerated natriuresis
during WI in hypertensive man.
Abnormally high natriuretic response to acute extracellular
fluid volume (ECFV) expansion has been extensively docu-
mented in arterial hypertension 11—3]. This so-called exagger-
ated natriuresis can be observed in hypertensive subjects during
infusion of isotonic or hypertonic saline, mannitol or dextrose
and water [1—5].
Both the very large fluid load and the subsequent changes in
plasma composition may be avoided by using head-out water
immersion (WI) in order to obtain isotonic-isooncotic central
fluid volume expansion in man [61. Indeed, recent studies have
shown that hypertensives may also exhibit exaggerated natri-
uresis during WI [7, 8].
Experimental evidence has been accumulated from normo-
tensive animals and humans suggesting that WI is associated
with reduced renal vascular resistance and increased deep
intrarenal venous pressure (IRVP) [9, 101. These changes in the
intrarenal physical factors may play a key role in determining
the natriuretic response observed during WI. In the present
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study we examine the renal hemodynamics, and especially the
IRVP behavior during ECFV expansion by WI in hypertensive




We studied six male subjects with sustained essential hyper-
tension (age range 25 to 45 years, mean body wt 76 4 kg). The
mean known duration of hypertension was three years (range I
to 10 years). All of these were defined as having sustained
arterial hypertension because their diastolic blood pressure was
found to be consistently above 100 mm Hg on the fifth day of
hospitalization and after 10 days withdrawal of any drug.
The diagnosis of essential hypertension was made according
to the usual clinical, roentgenographic and laboratory tests to
rule out any form of secondary hypertension. The patients had
no major signs and symptoms of target organ damage. In only
two patients moderate left ventricular hypertrophy, as assessed
by standard criteria, was recognized.
The results were compared with our previously reported
findings [10] in six healthy volunteer male subjects (age range 20
to 35 years, mean body wt 74 3 kg). All these had a negative
history for hypertension, cardiovascular disease and diabetes.
Renal disease was excluded by documenting a normal urine
sediment and creatinine clearance.
Methods
All subjects were put on a diet of constant sodium (150
mEq/day Na) and potassium (80 mEq/day K) content and the
study was performed when the urinary sodium excretion equaled
the intake; daily sodium output was monitored in 24 hour
samples for five days prior to the test. The observations were
made in the fasting state following 10 hours of fluid deprivation.
After a local anaesthesia with 1% lidocaine, percutaneous
retrograde catheterization of the renal vein was performed by
the method of Seldinger after puncture of right femoral vein: a
polyethylene catheter (outside diameter 0.9 mm) was gently
manipulated under fluoroscopy into a small division of the renal
vein as far peripherally as possible. The criteria for a satisfac-
tory intrarenal catheter position included a stable, clearly
pulsating pressure curve at a level higher than renal venous
pressure. Injection of minimal amounts of roentgen contrast
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medium through the catheter disclosed the catheter tip located
at the corticomedullary junction near the junction of the inter-
lobar and arcuate veins. The vascular puncture site was pro-
tected by means of a sterile, waterproof, adhesive dressing
(Tegaderm, Med. Prod. Division/3M, St. Paul, Minnesota,
USA).
The immersion study started at 09.00 hours; the subjects
voided and received 200 ml of tap water to drink. This water
load was repeated hourly throughout the study in order to
maintain adequate urine flow for the estimation of urine volume
by spontaneous voiding. An antecubital vein was catheterized
bilaterally for blood sampling and injection. Immediately after
voiding a priming dose of inulin and p-aminohippurate (PAH)
diluted in 0.9% saline was given into a forearm vein through an
indwelling needle in amounts calculated to attain plasma levels
of 25 and 1.5 mg/l00 ml, respectively. Then, sustaining infu-
sions of inulin and PAH were administered throughout the
study utilizing an infusion pump at rates (0.5 mI/mm) sufficient
to maintain satisfactory plasma levels. After an equilibration
period of 45 minutes, two basal, 30-minute clearance periods
were performed (preimmersion study), followed by four 30-
minute clearance periods (immersion study). The inulin and
PAH clearance were calculated according to the method of
Schnurr et al [11]. No correction was made for PAH renal
extraction; thus our determinations are designed as "effective
renal plasma flow" (ERPF). The subjects sat quietly outside of
the immersion tank for one hour (preimmersion period), then
the subjects stepped into the immersion tank and sat on a stool
with water to the neck at constant temperature (34.5 0.5°C)
with their arms outside of the tank. The subjects remained in
this tank for two hours and voided at hourly intervals.
At the end of each hour, before the subjects stood to void, 10
ml of blood was drawn for the estimation of osmolarity, plasma
proteins and hematocrit. The hourly urine volumes were mea-
sured and the concentrations of sodium and potassium were
determined.
Deep renal vein pressures were measured with a Statham
pressure transducer (the renal hilus was used as the zero
reference level) and recorded on a multichannel photographic
recorder (Battaglia Rangoni, Bologna, Italy); the pressure curves
did not change with respect to preset levels after the subjects
had moved for voiding. Blood arterial pressure was measured
non-invasively every five minutes with an automatic blood
pressure monitor (Arteriosonde Roche, model 1225, Basel,
Switzerland) and every 10 minutes with a standard mercury
manometer.
Urinary sodium and potassium were determined with a flame
photometer.
Inulin was termined colorimetrically according to anthrone
method of Young and Raisz [12] and PAH by method of Smith
et al [13]. The values for the individual clearance period were
corrected to 1.73 m2 body surface area and the mean value for
the preimmersion period and the immersion period was calcu-
lated.
Filtration fraction (FF) was calculated as the Cjfl/CPAH ratio
(%); hematocrit was measured using a hematocrit centrifuge.
Afferent arteriolar plasma protein concentration (CA) was de-
lined as the plasma concentration in peripheral venous blood;
efferent arteriolar plasma protein concentration (CE) was calcu-
lated from the filtration fraction and from CA using the relation-
Table 1. Clinical and laboratory findings in six control and six






I 72 32 87 171
2 74 35 97 173
3 76 20 93 130
4 77 33 90 141
5 71 20 85 104
6 74 35 98 153
74 29 92 145
1 3 I 4
ship CE = CA/I — FF. Values for afferent (HA) and efferent (HE)
plasma oncotic pressures were then derived from CA and CE
using the relationship: fl (mm Hg) = 1.629 C + 0.2935 C2 [14].
In the calculation of the renal vascular resistance the follow-
ing equation was used [15]:
precapillary — MAP — IRVP (mm Hg)
resistance — RBF (mllmin)
x 8 x iO (dyne sec cm5)
where MAP is mean arterial pressure, IRVP is intrarenal
venous pressure and RBF is renal blood flow, obtaind by
dividing ERPF for (1-hematocrit).
Statistical calculations were carried out with the non-parame-
tric Wilcoxon matched pairs sign-rank test and the Mann
Whitney U-test for comparisons between groups. The null
hypothesis was rejected when P  0.05. In the presentation of
the data, mean values are followed by the SEM as an index of
dispersion. The purpose of the study, the experimental proce-
dure and its possible risk factors were explained to the subjects.
No complications, such as air embolism, infection, thrombosis,
hemorrhage or dye reactions occurred. The protocol has been
approved by the Ethical Committee at the Institute of Semei-
otica Medica. The investigation has been conducted in confor-
mity with the basic principles embodied in the Declaration of
Helsinki.
Results
Table I shows some clinical and laboratory findings in control
and hypertensive subjects.
Urine flow (V/mm) and urinary excretion of sodium (UNaV)
and potassium (UKV) were similar in hypertensive patients and
controls during the preimmersion period (Table 2). During WI,
the increase in UNaV was significantly greater in hypertensives.
The peak value of UNaV was reached during the second hour of
WI in both groups: it was 535 15 smol/min (range 503 to 600)















1 80 42 130 176
2 76 45 140 138
3 72 36 117 150
4 70 25 143 161
5 78 45 130 158
6 79 30 127 170
76 37 131 159
2 3 2 2
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C 1.3 0.1 111 3 50 8 26.6 0.4
WI (1 hr) 5.6 0.3 331 l4 194 l8 26.7 0.4
WI (2 hr) 8.7 0.? 535 1? 274 26 27.2 0.4
P 0.05 0.05 0.05 NS
(C-2 hr) +7.4 0.5 +424 I4 +224 2V —0.6 0.9
Normotensives
C 1.1±0.1 99±9 64±8 26.8±0.6
WI(lhr) 3.4±0.2 157±9 117±13 26.8±0.5
WI (2 hr) 6.9 1.0 300 28 157 22 26.7 0.2
P 0.05 0,05 0.05 NS
(C-2 hr) +5.8 1.0 +201 25 +93 19 +0.5 0.4
Values are mean SEM. P  0.05 from C to both first and second hour of WI. (C-2 hr) is positive or negative difference between control condi-
tion and 2nd hour of WI.
Abbreviations are: C, control condition; WI, water immersion; V, urine flow; UNaV, sodium excretion; UKV, potassium excretion; rA, venous
colloid osmotic pressure.
a Significantly different (P  0.05) from corresponding value in normotensive group







C 108 4 511 iia 21 l 38.3 l.2a
WI (I hr) 114 3 694 10 16 0.5 35.4 0.8
WI(2 hr) Ill 4 742 12 15 0.4 35.2 0.
P NS 0.05 0.05 0.05
A(C-2 hr) +3 I +231 1? —6.2 0.7a —3.1 1.3
Normotensives
C 109 4 629 34 17.5 0.5 36.5 0.7
WI(lhr) 114±4 720±38 15.8±0.7 35.1±0.7
WI (2 hr) 113 4 738 42 15.4 0.5 34.7 0.4
P NS 0.05 0.05 0.05
A(C-2 hr) +4 1 +109 10 —2.1 0.2 —1.7 0.5
Abbreviatlions are: C10, inulin clearance: CPAH, clearance of p-aminohippurate; FF, Clfl/CPAH; ITE, efferent arteriolar colloid osmotic pressure;
(C-2 hr), positive or negative difference between control condition and 2nd hour of WI.
Values are mean SEM. P  0.05 from C to both first and second hour of WI.
a Significantly different (P 0.05) from corresponding value in normotensive group
normotensives (P < 0.05). The increase in UNaV from baseline
values to second hour of immersion [0 to 2 hr)j was uniformly
much greater in hypertensives, thus showing exaggerated natri-
uresis in alt hypertensives. Both V/mm and UKV were higher
during WI in hypertensives with respect to normotensives.
Serum protein concentration and derived values of 11A (Table 2)
as well as plasma sodium, potassium and hematrocit (not
shown) were not modified by WI.
Renal hemodynamics
Under baseline conditions, ERPF was significantly reduced
in our hypertensive patients (511 II mI/mm vs. 629 34 in
normotensive controls; P < 0.05) (Table 3).
GFR was similar in hypertensive (108 4 mI/mm) and
normotensive subjects (109 4 mI/mm). The FF was signifi-
cantly increased in hypertensive subjects (21 1%) in compar-
ison with normotensives (17.5 0.5%; P < 0.05); H was
higher in hypertensives (38.3 1.2 mm Hg) when compared to
controls (36.5 0.7 mm Hg; P < 0.05).
During WI, GFR was unchanged while ERPF (CPAH) rose
significantly in both groups. The ERPF increased during both
first and second hour of WI and reached quite identical levels in
hypertensive and normotensive subjects; however, the increase
from baseline values was greater in the hypertensive than in
normotensive group (P < 0.05). Consequently, both FF (P <
0.05) and 11E (not significantly) fell during WI to a greater extent
in hypertensive than in normotensive subjects.
MAP did not appreciably change in the normotensive group
(Table 4), while it significantly fell in hypertensive (P < 0.05)
versus baseline during both first and second hour of WI.
However, MAP remained elevated above normal values, show-
ing a significant difference versus the corresponding MAP in the
normotensive group. The time course of MAP in control and
hypertensive subjects is represented in Figure 1.
Mean baseline values of IRVP were identical in normotensive
(18.2 1.4 mm Hg) and hypertensive subjects (18.0 0.7 mm
Hg). IRVP rose during WI reaching a peak value of 32 1.7 mm
Hg in normotensives (P < 0.05) and of 41 1.4 mm Hg in
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MAP IRVP
mm Hg dyne sec' cm5
Essential hypertensives
C 133 3 18 0.7 10286 433
WI (I hr) 121 3 34 1.6 5641 241k
WI (2 hr) 120 3 41 I.4 4930 l30
P 0.05 0.05 0.05
i(C-2 hr) —13 2 —22.8 l.la —5362 785
Normotensives
C 91 2 18.2 1.4 5357 363
WI (1 hr) 89 2 29.3 1.5 3816 205
WI (2 hr) 87 2 32 1.7 3378 152P NS 0.05 0.05
(C-2hr) —7±2 —14±1.2 —1979±784
Abbreviations are: MAP, mean arterial pressure; IRVP, intrarenal
venous pressure; (C-2 hr), negative difference between control condi-
tion and 2nd hour of WI.
Values as mean SEM. P 0.05 from C to both first and second hour
of WI.




hypertensives (P < 0.05). IRVP was significantly higher in
hypertensives than in normotensives during both first and
second hour of WI (P < 0.05).
The PVR was significantly elevated during the preimmersion
period in hypertensives (10286 433 vs. 5357 363 dyne . sec
cm5; P < 0.05). PVR was markedly reduced during Wi in both
groups (P < 0.05); the fall in PVR was significantly greater
during both the first and second hour of WI in hypertensives
(—52%) than it was in normotensives (—37%; P < 0.05).
Figure 2 represents the mean values of UNaV as a function of
IRVP during the basal period, the first and the second hour of
WI in six normotensive and six hypertensive subjects.
Discussion
Under control conditions, diuresis volume and sodium excre-
tion, as well as hematocrit and plasma protein concentration in
hypertensives, were not different from those of normotensives.
This indicates that both hydration and sodium balance (Table 1)
were similar in the two groups.
Our findings show that under basal conditions, IRVP is the
same in hypertensive and normotensive subjects. Normal IRVP
has been observed by Willassen and Ofstad [151in hypertensive
man, while Lowenstein et al [5] found a substantial increase in
IRVP in a group of essential hypertensives. However, these
latter authors performed their IRVP measurements during
mannitol infusion. Previous observations have shown that
IRVP, measured with the present technique (wedged, deep
intrarenal venous pressure), may be a satisfactory expression of
the hydrostatic pressure in the smallest peritubular capillaries
as suggested by Brun et al [16]. In the rat, wedged renal vein
pressure closely approximates proximal tubular and peritubular
capillary pressure (171. In the dog, IRVP measurements are
comparable to values obtained by direct needle measurements
of intrarenal pressure [18], In both dog [191 and man [5] different
maneuvers, known to be able to change periotubular hydro-
static pressure (aortic or renal vein constriction, increase in
ureteropelvic pressure, pharmacological renal vasoconstriction
or dilation), have been shown to be associated with side
changes in 1RVP. In the dog, these variations in IRVP have
been paralleled by consistent changes in directly needle mea-
sured intrarenal pressure (19].
A normal IRVP in hypertensives was associated with a low
ERPF and a high PVR, both well-known findings in essential
hypertension [20, 21]. This suggests that renal vasoconstriction
does not permit the transmission of increased renal perfusion
pressure beyond renal arterioles to postglomerular capillaries.
During WI, the renal vasoconstriction was reduced in hyper-
Table 4. Effects of water immersion (WI) on mean arterial pressure,
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Fig. 2. Mean values (± SEM,) of urinary sodium excretion (UV,) as a
function of intrarenal venous pressure (JR VP) (mean values SEMI
before (C) and at first (1) and second (2) hour of water i,n,nersion in six
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Fig.1. Time course of mean arterial pressure befhre and during waler
immersion in six normotensive and in six hypertensive subjects.
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tensive patients who showed a more marked renal vasodilation
than control subjects. Furthermore, systemic arterial pressure
was significantly reduced by WI in hypertensives, but it re-
mained, by far, more elevated than in the control group. Renal
vasodilation was associated with a greater increase in both
IRVP and sodium excretion (exaggerated natriuresis) with
respect to normotensive subjects. From this, we were able to
infer that the transmission of higher systemic pressure to the
peritubular capillaries, in the presence of renal vasodilation,
produced the more elevated IRVP and subsequently an exag-
gerated natriuresis in hypertensives during WI. This view well
agrees with the suggestion that renal interstitial hydrostatic
pressure is the crucial factor linking renal hemodynamic changes
to sodium excretion [22, 23].
Both FF and estimated peritubular capillary oncotic pressure
(flE) were increased in hypertensives under basal conditions
[15, 20] and they fell more than in controls subjects with WI,
although only FF was statistically significant. However, both
FF and 11E were the same in hypertensives and normotensives
throughout WI. Therefore it is very unlikely that transient
differences in the time course of FF and HE may explain the
maximally exaggerated natriuretic response observed during
the second hour of WI.
Willassen and Ofstad [15] investigated the possible role of
changes in IRVP in hypertensive patients exhibiting exagger-
ated natriuresis during saline infusion. They concluded that
physical factors were not involved in the saline-induced exag-
gerated natriuresis observed in only a few hypertensive sub-
jects.
However, their experiment, unlike WI, was unable to induce
any significant change in IRVP in both control and hypertensive
subjects. Thus, it may be difficult to compare results obtained
under these two very different experimental conditions. In
addition, the MAP of their hypertensives was largely lower (110
3 SEM mm Hg) than that of our hypertensive group. Finally,
Lowenstein et al [5] observed that exaggerated natriuresis
during saline infusion in hypertensive subjects was associated
with a further increase in their baseline elevated IRVP.
Epstein, Loutzenhiser and Levinson [7] recently observed
exaggerated natriuresis during WI only in 4 out of their 27
hypertensive subjects. In this subset of hypertensives they
found a significant increase in endogenous creatinine clearance
during the third hour of WI, while it was unchanged during the
first two hours in the presence of marked hypernatriuresis.
Consequently, those data clearly confirm that exaggerated
natriuresis in hypertensives may occur without significant changes
in GFR.
In addition, these authors did not measure blood pressure
during WI. Therefore, they were unable to rule out the contri-
bution of changes in the MAP to the variable natriuretic
response. Finally, they performed their studies in patients with
very restricted sodium intake (10 mEq/day), and a relationship
between the reduced basal level of plasma renin activity and the
exaggerated natriuretic response to WI emerged from their
findings.
Our previous study [8] has shown that exaggerated natriure-
sis occurs in hypertensives when their MAP values remain
elevated during WI. The natriuretic response in those hyper-
tensive patients, showing a fall in MAP toward the normal range
during WI, was similar to that measured in normotensive
controls. Plasma renin activity and plasma aldosterone were
similarly suppressed in hypertensive and control subjects dur-
ing WI, irrespective of the pressor or natriuretic response [8].
This relationship between high actual MAP and exaggerated
natriuresis during volume expansion is in agreement with the
previous reports showing that exaggerated natriuresis induced
by saline infusion is blunted or abolished during antihyperten-
sive treatment [24, 25].
In conclusion, the present study demonstrates that hyperten-
sive patients exhibit an exaggerated natriuretic response to
central volume expansion by WI, at least when their sodium
intake is not restricted and their blood pressure remains ele-
vated during WI. Under these experimental conditions, exag-
gerated natriuresis seems to be well explained by the more
marked hemodynamic changes induced by WI in hypertensives.
The enhanced renal vasodilation, in the presence of sustained
systemic hypertensive, could induce a more pronounced rise in
intrarenal venous pressure (that is, peritubular capillary hydro-
static pressure), thus resulting in exaggerated natriuresis.
Reprint requests to Dr. Paolo Coruzzi, Istizuto di Se,neiotica Medica,
Università degli Studi di Par,na, Via Grarnsci, /4, 43/00Par,na, Itah'.
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